People · Operator
Named in public records as an officer, director or promoter · active 2011–2026 · Healthtech, Biotechnology, Pharmaceuticals, Other Technology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vertos Medical Inc | — | Healthtech | Series C | $177.3M | $513.6M | 2014 |
| TScan Therapeutics, Inc. | — | Biotechnology | Series C | $123.3M | $3.3B | 2021 |
| Altesa BioSciences, Inc. | — | Pharmaceuticals | Series C | $110.0M | $373.5M | 2022 |
| Valeritas Inc | — | Other Technology | Series C | $106.5M | $689.9M | 2011 |
| HomeThrive, Inc. | — | Other Health Care | Series B | $35.3M | $131.8M | 2024 |
| ImmuneID, Inc. | — | Biotechnology | Series B | $17.1M | $548.3M | 2020 |
Ittai Harel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ittai Harel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Ryan | 2 | 17 |
| Christoph Westphal | 2 | 8 |
| Daniel Pelak | 2 | 5 |
| Lea Hachigian | 2 | 2 |
| Andrew Firlik | 1 | 14 |
| David Greenberg | 1 | 13 |
| Todd Foley | 1 | 12 |
| Bruce Feuchter | 1 | 12 |
| Glen Tullman | 1 | 12 |
| LEE SHAPIRO | 1 | 10 |
| Campbell Murray | 1 | 9 |
| Robert Garber | 1 | 8 |
| Robert Crane | 1 | 7 |
| Myles Greenberg | 1 | 6 |
| Steve Kraus | 1 | 6 |
| Timothy Barberich | 1 | 6 |
| David Jacobs | 1 | 5 |
| Daniel M. Watkins | 1 | 5 |
| Seth Rudnick | 1 | 5 |
| Andrew Hedin | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.